Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies.
Utley
M
M
Gallivan
S
S
Young
A
A
Cox
N
N
Davies
P
P
Dixey
J
J
Emery
P
P
Gough
A
A
James
D
D
Prouse
P
P
Williams
P
P
Winfield
J
J
Devlin
J A
JA
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012219:Rheumatology / Q000379:methods*; D012460:Sulfasalazine / Q000627:therapeutic use; D016019:Survival Analysis
D018501:Antirheumatic Agents; D012460:Sulfasalazine